[What is guaranteed in the treatment of gastrointestinal endocrine tumors?]
Related Experiment Videos
M E Trautmann1, H Koop, R Arnold
1Zentrum für Innere Medizin, Philipps-Universität Marburg.
Der Internist
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification.
Diabetic medicine : a journal of the British Diabetic Association·2018
[Choosing wisely recommendations in gastroenterology].
Der Internist·2017
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment.
Diabetes, obesity & metabolism·2012
[Splenic injury after colonoscopy: a retrospective study and review of the literature].
Deutsche medizinische Wochenschrift (1946)·2009
Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Nivolumab dose stewardship in routine Oncology practice: a real-world health-economic simulation.
Expert review of pharmacoeconomics & outcomes research·2026
Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy.
Revista do Colegio Brasileiro de Cirurgioes·2026
An Optimized Cancer Cachexia Research Model.
Current protocols·2026
Vitamin C for the prevention of complex regional pain syndrome after foot and ankle fractures or surgery: a systematic review.
European review for medical and pharmacological sciences·2026
Macrophages Are Not Welcome: Potential of CCR1/CCR2 Inhibition for Cytokine Release Prevention.
Cancer immunology research·2026